Quantitative mRNA analysis of serotonin 5-HT4 and adrenergic β2 receptors in the mouse embryonic telencephalon

Developmental Neuroscience

Volumn 32, Issue 4, 2010, Pages 278-287

  Hernandez, Melissa C ^a   Janušonis, Skirmantas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 hydroxytryptamine; Autism spectrum disorders; Brain development; Cerebral cortex; Depression; Nested genes; Norepinephrine; Quantitative real time RT PCR; Stress

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; MESSENGER RNA; SEROTONIN 4 RECEPTOR;

ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HOUSEKEEPING GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TELENCEPHALON; THALAMOCORTICAL TRACT; UPREGULATION;

ANIMALS; EMBRYO, MAMMALIAN; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, SEROTONIN, 5-HT4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELENCEPHALON;

EID: 78650516695     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314723     Document Type: Article

References (70)

1. 2-adrenoceptor induced synaptic facilitation in rat basolateral amygdala. Brain Res 2008;1209:65-73.
2. Assis R, Kondrashov AS, Koonin EV, Kondrashov FA: Nested genes and increasing organizational complexity of metazoan genomes. Trends Genet 2008;24:475-478.
3. Barthet G, Gaven F, Framery B, Shinjo K, Nakamura T, Claeysen S, Bockaert J, Dumuis A: Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors: distinct molecular events with different GRK2 requirements. J Biol Chem 2005;280:27924-27934.
4. 4 receptors in living cells. FEBS Lett 2005;579:2973-2980.
5. 4 receptor dimerization. Biochem Biophys Res Commun 2007;356:642-647.
6. Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P: Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 2006;326:553-572.
7. 4 receptors. Curr Drug Targets CNS Neurol Disord 2004;3:39-51.
8. Bruning G, Liangos O, Baumgarten HG: Prenatal development of the serotonin transporter in mouse brain. Cell Tissue Res 1997;289:211-221.
9. Bustin SA, Nolan T (2009): Data Analysis and Interpretation; in Bustin SA (ed): A-Z of Quantitative PCR. La Jolla, International University Line, pp 441-492.
10. Castillo-Davis CI, Mekhedov SL, Hartl DL, Koonin EV, Kondrashov FA: Selection for short introns in highly expressed genes. Nat Genet 2002;31:415-418.
11. 2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatry 2007;12:283-291.
12. 4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 1999;55:910-920.
13. 2-Adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol 2005;20:876-884.
14. Crampton N, Bonass WA, Kirkham J, Rivetti C, Thomson NH: Collision events between RNA polymerases in convergent transcription studied by atomic force microscopy. Nucleic Acids Res 2006;34:5416-5425.
15. 2 adrenergic receptor signaling complex assembled with the Ca 2+ channel Cav1.2. Science 2001;293:98-101.
16. 4 receptor splice variants including a functional homofusion variant. Physiol Genomics 2008;34:22-33.
17. Diego MA, Jones NA, Field T, Hernandez-Reif M, Schanberg S, Kuhn C, Gonzalez-Garcia A: Maternal psychological distress, prenatal cortisol, and fetal weight. Psychosom Med 2006;68:747-753.
18. Dixon WJ: Ratios involving extreme values. Ann Math Stat 1951;22:68-78.
19. Duman RS: A silver bullet for the treatment of depression? Neuron 2007;55:679-681.
20. Ebert SN, Rong Q, Boe S, Pfeifer K: Catecholaminesynthesizing cells in the embryonic mouse heart. Ann N Y Acad Sci 2008;1148:317-324.
21. Efstathiou CE: Estimation of type I error probability from experimental Dixon's 'Q' parameter on testing for outliers within small size data sets. Talanta 2006;69:1068-1071.
22. Elias M, Deacon T, Caviness VS Jr: The development of neocortical noradrenergic innervation in the mouse: a quantitative radioenzymatic analysis. Brain Res 1982;255:652-656.
23. Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007;132:397-414.
24. Gibson CW, Thomson NH, Abrams WR, Kirkham J: Nested genes: biological implications and use of AFM for analysis. Gene 2005;350:15-23.
25. Henikoff S, Eghtedarzadeh MK: Conserved arrangement of nested genes at the Drosophila Gart locus. Genetics 1987;117:711-725.
26. Janušonis S: Origin of the blood hyperserotonemia of autism. Theor Biol Med Model 2008;5:10.
27. Janušonis S, Gluncic V, Rakic P: Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. J Neurosci 2004;24:1652-1659.
28. 2-adrenergic receptor-GluR1 signalling complex for localized cAMP signalling. EMBO J 2010;29:482-495.
29. 2-ARs in the Developing Telencephalon Dev Neurosci 2010;32:278-287
30. 4) receptor. Biochem Pharmacol 2005;70:1009-1018.
31. Kitchen RR, Kubista M, Tichopad A: Statistical aspects of quantitative real-time PCR experiment design. Methods 2010;50:231-236.
32. Kumar A: An overview of nested genes in eukaryotic genomes. Eukaryot Cell 2009;8:1321-1329.
33. 2-and β 3-adrenergic receptors increases brain tryptophan. J Pharmacol Exp Ther 2003;305:653-659.
34. Levitt P, Moore RY: Development of the noradrenergic innervation of neocortex. Brain Res 1979;162:243-259.
35. 4 receptor and Alzheimer's disease: the amyloid connection. Exp Neurol 2007;205:325-329.
36. Lidov HG, Molliver ME: An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull 1982;8:389-430.
37. 4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol 2005;289: G1148-G1163.
38. Liu Y, Wu Y, Lee JC, Xue H, Pevny LH, Kaprielian Z, Rao MS: Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 2002;40:25-43.
39. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ: β-Arrestin: a protein that regulates β-adrenergic receptor function. Science 1990;248:1547-1550.
40. 4) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007;55:712-725.
41. 4 receptor mRNA. Biochem J 2005;387:463-471.
42. 4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res Mol Brain Res 2001;90:125-134.
43. Miyata T, Kawaguchi D, Kawaguchi A, Gotoh Y: Mechanisms that regulate the number of neurons during mouse neocortical development. Curr Opin Neurobiol 2010;20:22-28.
44. Mnie-Filali O, Amraei MG, Benmbarek S, Archer-Lahlou E, Penas-Cazorla R, Vilaro MT, Boye SM, Pineyro G: Serotonin 4 receptor (5-HT 4 R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B. Cell Signal 2010;22:501-509.
45. Molnar Z, Adams R, Blakemore C: Mechanisms underlying the early establishment of thalamocortical connections in the rat. J Neurosci 1998;18:5723-5745.
46. Mongeau R, Blier P, de Montigny C: The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 1997;23:145-195.
47. Newnham JP, Marshall CL, Padbury JF, Lam RW, Hobel CJ, Fisher DA: Fetal catecholamine release with preterm delivery. Am J Obstet Gynecol 1984;149:888-893.
48. O'Donnell K, O'Connor TG, Glover V: Prenatal stress and neurodevelopment of the child: focus on the HPA axis and role of the placenta. Dev Neurosci 2009;31:285-292.
49. Parga J, Rodriguez-Pallares J, Munoz A, Guerra MJ, Labandeira-Garcia JL: Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors. Dev Neurobiol 2007;67:10-22.
50. Pellissier LP, Sallander J, Campillo M, Gaven F, Queffeulou E, Pillot M, Dumuis A, Claeysen S, Bockaert J, Pardo L: Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors. Mol Pharmacol 2009;75:982-990.
51. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP: Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excelbased tool using pair-wise correlations. Biotechnol Lett 2004;26:509-515.
52. 2- adrenoceptors in basolateral nucleus of amygdala and their roles in consolidation of fear memory in rats. Hippocampus 2008;18:1131-1139.
53. 4 receptor splice variant (r5-HT (4c1)) and preliminary characterisation of specific 5-HT (4a) and 5-HT (4b) receptor antibodies. Eur J Pharmacol 2009;604:1-11.
54. Rorabacher DB: Statistical treatment for rejection of deviant values: Critical values of Dixon's 'Q' parameter and related subrange ratios at the 95% confidence level. Anal Chem 1991;63:139-146.
55. 2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide. Brain Res 2001;898:242-255.
56. 4 receptors in the mouse developing thalamocortical projections. Dev Neurobiol 2010;70:165-181.
57. 4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1205-1210.
58. Tichopad A, Dilger M, Schwarz G, Pfaffl MW: Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res 2003;31: e122.
59. Tichopad A, Kitchen R, Riedmaier I, Becker C, Stahlberg A, Kubista M: Design and optimization of reverse-transcription quantitative PCR experiments. Clin Chem 2009;55:1816-1823.
60. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3: RESEARCH0034.
61. Verney C, Berger B, Baulac M, Helle KB, Alvarez C: Dopamine-β- hydroxylase-like immunoreactivity in the fetal cerebral cortex of the rat: noradrenergic ascending pathways and terminal fields. Int J Dev Neurosci 1984;2:491-503.
62. 4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol 2005;484:418-439.
63. Vincent JB, Noor A, Windpassinger C, Gianakopoulos PJ, Schwarzbraun T, Alfred SE, Stachowiak B, Scherer SW, Roberts W, Wagner K, Kroisel PM, Petek E: Characterization of a de novo translocation t (5; 18) (q33.1;q12.1) in an autistic boy identifies a breakpoint close to SH3TC2, ADRB2, and HTR4 on 5q, and within the desmocollin gene cluster on 18q. Am J Med Genet B Neuropsychiatr Genet 2009;150 B: 817-826.
64. 4 binding sites in rat brain. Behav Brain Res 1996;73:259-262.
65. 4 binding sites in rodent brain. Neuropharmacology 1994;33:527-541.
66. Wallace JA, Lauder JM: Development of the serotonergic system in the rat embryo: an immunocytochemical study. Brain Res Bull 1983;10:459-479.
67. Yirmiya N, Charman T: The prodrome of autism: early behavioral and biological signs, regression, peri-and post-natal development and genetics. J Child Psychol Psychiatry 2010;51:432-458.
68. 2-adrenergic receptor gene influence Alzheimer's disease susceptibility. Brain Res 2008;1210:216-222.
69. 2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production. Brain Res 2010;1317:305-310.
70. Yu P, Ma D, Xu M: Nested genes in the human genome. Genomics 2005;86:414-422.